Sunday, October 1, 2023
Disclosures
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, reviewers, and others in a position to control the content of this activity disclose to learners the presence or absence of any relevant financial relationships with an ACCME-defined ineligible company within the preceding 24 months of the activity. The ACCME defines an “ineligible company” as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Our goal is to ensure that there is no compromise in the ethical relationship that exists between those in a position to control the content of the activity and those participating in the activity and their respective professional duties. All accredited education activities offered by National Jewish Health are reviewed to ensure a balanced and evidence-based presentation.
All relevant financial relationships among individuals in a position to control the content of this activity have been identified and mitigated according to the Standards of Integrity and Independence in Accredited Continuing Education.
Unlabeled and Investigational Usage
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses.
Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.
Disclaimer Statement
National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.
By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.
Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.
Director, The Respiratory Centers of Excellence
Medical Director, Lung Cancer Screening Program
Professor, Division of Pulmonary, Critical Care & Sleep Medicine
Division of Oncology, Cancer Center
Department of Medicine
National Jewish Health
Denver, Colorado, United States
Section Head, Critical Care Medicine
Professor of Medicine
Section of Critical Care Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine
National Jewish Health
Denver, Colorado, United States
Family Nurse Practitioner
Adult Pulmonary Clinic
Division of Pulmonary, Critical Care & Sleep Medicine National Jewish Health
Denver, Colorado, United States
Assistant Professor of Medicine
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Chief Medical Officer
Chief, Division of Hospital & Internal Medicine
Associate Professor of Medicine
National Jewish Health
Denver, Colorado, United States
Professor of Pulmonary Medicine
ErasmusMC and UGent
Director, VIB Inflammation Research Center
Ghent, Belgium
Elyce Bowron, MEd, has no relevant financial relationships.
Meghan Brenner, MA, has no relevant financial relationships.
Mandy Comeau has no relevant financial relationships.
James H. Finigan, MD, has no relevant financial relationships.
Andrea Harshman, MHA, CHCP, CMP-HC, has no relevant financial relationships.
William J. Janssen, MD, has no relevant financial relationships.
Ann Mullen, RN, CNS, CDE, has no relevant financial relationships.
Joshua Solomon, MD, has no relevant financial relationships.
Physicians - maximum of 1.50 AMA PRA Category 1 Credit(s)™
Nurses - 1.50 contact hour(s) (0 contact hours are in the area of pharmacology)
Pharmacists - 1.50 Knowledge-based ACPE (0.150 CEUs)
US: hospitalists, pulmonologists, internal medicine, emergency medicine, critical care, infectious disease specialists, registered nurses, NPs and PAs, clinical pharmacists
EU and Global: pulmonologists, critical care, emergency medicine, internal medicine, and infectious disease specialists
This educational program will cover the pathophysiology of COVID-19 and how our understanding of this guides therapeutic decisions. The multidisciplinary faculty panel will discuss communication strategies with patients, American and European guidelines for the in-patient treatment of COVID-19, including supportive therapies and strategies for special populations, as well as management of patients post-hospitalization and patients with long COVID. Lastly, we will discuss clinical trials of new and emerging treatments.
Upon completion of this activity, participants will be able to:
Disclosures
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, reviewers, and others in a position to control the content of this activity disclose to learners the presence or absence of any relevant financial relationships with an ACCME-defined ineligible company within the preceding 24 months of the activity. The ACCME defines an “ineligible company” as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Our goal is to ensure that there is no compromise in the ethical relationship that exists between those in a position to control the content of the activity and those participating in the activity and their respective professional duties. All accredited education activities offered by National Jewish Health are reviewed to ensure a balanced and evidence-based presentation.
All relevant financial relationships among individuals in a position to control the content of this activity have been identified and mitigated according to the Standards of Integrity and Independence in Accredited Continuing Education.
Unlabeled and Investigational Usage
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses.
Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.
Disclaimer Statement
National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.
By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.
Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.
Director, The Respiratory Centers of Excellence
Medical Director, Lung Cancer Screening Program
Professor, Division of Pulmonary, Critical Care & Sleep Medicine
Division of Oncology, Cancer Center
Department of Medicine
National Jewish Health
Denver, Colorado, United States
Section Head, Critical Care Medicine
Professor of Medicine
Section of Critical Care Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine
National Jewish Health
Denver, Colorado, United States
Family Nurse Practitioner
Adult Pulmonary Clinic
Division of Pulmonary, Critical Care & Sleep Medicine National Jewish Health
Denver, Colorado, United States
Assistant Professor of Medicine
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Chief Medical Officer
Chief, Division of Hospital & Internal Medicine
Associate Professor of Medicine
National Jewish Health
Denver, Colorado, United States
Professor of Pulmonary Medicine
ErasmusMC and UGent
Director, VIB Inflammation Research Center
Ghent, Belgium
Elyce Bowron, MEd, has no relevant financial relationships.
Meghan Brenner, MA, has no relevant financial relationships.
Mandy Comeau has no relevant financial relationships.
James H. Finigan, MD, has no relevant financial relationships.
Andrea Harshman, MHA, CHCP, CMP-HC, has no relevant financial relationships.
William J. Janssen, MD, has no relevant financial relationships.
Ann Mullen, RN, CNS, CDE, has no relevant financial relationships.
Joshua Solomon, MD, has no relevant financial relationships.
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
National Jewish Health designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
European Physicians:
The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMEC®s) should contact the UEMS at [email protected]
Provider approved by the California Board of Registered Nursing, Provider Number 12724 for 1.5 contact hours.
National Jewish Health is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
National Jewish Health designates this enduring material for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: UAN 0831-0000-22-006-H01-P. Activity Type: Knowledge-based.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 80% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / CE Released: 1/20/2023
Valid for credit through: 1/20/2024, 11:59 PM EST
processing....
Before you begin, please take this brief survey.
